| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |